Literature DB >> 17925434

Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.

Jude Kendall1, Qing Liu, Amy Bakleh, Alex Krasnitz, Ken C Q Nguyen, B Lakshmi, William L Gerald, Scott Powers, David Mu.   

Abstract

We used high-resolution array analysis to discover a recurrent lung cancer amplicon located at 14q13.3. Low-level gain of this region was detected in 15% of lung cancer samples, and high-level amplification was detected in an additional 4% of samples. High-level focal amplification appears to be specific to lung cancers, because it was not detected in >500 samples of other tumor types. Mapping of the commonly amplified region revealed there are three genes in the core region, all of which encode transcription factors with either established lung developmental function (TTF1/NKX2-1, NKX2-8) or potential lung developmental function (PAX9). All three genes were overexpressed to varying degrees in amplified samples, although TTF1/NKX2-1 was not expressed in the squamous cancer subtype, consistent with previous reports. Remarkably, overexpression of any pairwise combination of these genes showed pronounced synergy in promoting the proliferation of immortalized human lung epithelial cells. Analysis of human lung cancer cell lines by both RNAi and ectopic overexpression further substantiates an oncogenic role for these transcription factors. These results, taken together with previous reports of oncogenic alterations of transcription factors involved in lung development (p63, CEBPA), suggest genetic alterations that directly interfere with transcriptional networks normally regulating lung development may be a more common feature of lung cancer than previously realized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925434      PMCID: PMC2034240          DOI: 10.1073/pnas.0708286104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

Review 3.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.

Authors:  Xiaojun Zhao; Barbara A Weir; Thomas LaFramboise; Ming Lin; Rameen Beroukhim; Levi Garraway; Javad Beheshti; Jeffrey C Lee; Katsuhiko Naoki; William G Richards; David Sugarbaker; Fei Chen; Mark A Rubin; Pasi A Jänne; Luc Girard; John Minna; David Christiani; Cheng Li; William R Sellers; Matthew Meyerson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

5.  Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.

Authors:  C Di Loreto; V Di Lauro; F Puglisi; G Damante; D Fabbro; C A Beltrami
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

6.  Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma.

Authors:  A Khoor; J A Whitsett; M T Stahlman; S J Olson; P T Cagle
Journal:  Hum Pathol       Date:  1999-06       Impact factor: 3.466

7.  Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.

Authors:  Minsub Shim; Kristina L Powers; Sarah J Ewing; Songyun Zhu; Robert C Smart
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

8.  High-resolution genomic profiles of human lung cancer.

Authors:  Giovanni Tonon; Kwok-Kin Wong; Gautam Maulik; Cameron Brennan; Bin Feng; Yunyu Zhang; Deepak B Khatry; Alexei Protopopov; Mingjian James You; Andrew J Aguirre; Eric S Martin; Zhaohui Yang; Hongbin Ji; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

9.  TTF-1 gene expression in human lung tumours.

Authors:  D Fabbro; C Di Loreto; O Stamerra; C A Beltrami; R Lonigro; G Damante
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

10.  Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.

Authors:  Hisaaki Tanaka; Kiyoshi Yanagisawa; Keiko Shinjo; Ayumu Taguchi; Ken Maeno; Shuta Tomida; Yukako Shimada; Hirotaka Osada; Takayuki Kosaka; Hideo Matsubara; Tetsuya Mitsudomi; Yoshitaka Sekido; Mitsune Tanimoto; Yasushi Yatabe; Takashi Takahashi
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

View more
  119 in total

1.  Functional Enhancers Shape Extrachromosomal Oncogene Amplifications.

Authors:  Andrew R Morton; Nergiz Dogan-Artun; Zachary J Faber; Graham MacLeod; Cynthia F Bartels; Megan S Piazza; Kevin C Allan; Stephen C Mack; Xiuxing Wang; Ryan C Gimple; Qiulian Wu; Brian P Rubin; Shashirekha Shetty; Stephane Angers; Peter B Dirks; Richard C Sallari; Mathieu Lupien; Jeremy N Rich; Peter C Scacheri
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

2.  Going beyond the genetic view of cancer.

Authors:  Razvan Tudor Radulescu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

Review 3.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

4.  William L Gerald, M. D., Ph.D., 1954-2008.

Authors:  Marc Ladanyi
Journal:  J Mol Diagn       Date:  2009-01       Impact factor: 5.568

5.  TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.

Authors:  Z Liu; K Yanagisawa; S Griesing; M Iwai; K Kano; N Hotta; T Kajino; M Suzuki; T Takahashi
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

Review 6.  Resident cellular components of the lung: developmental aspects.

Authors:  Wellington V Cardoso; Jeffrey A Whitsett
Journal:  Proc Am Thorac Soc       Date:  2008-09-15

Review 7.  Update in lung cancer 2007.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2008-05-01       Impact factor: 21.405

8.  Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.

Authors:  Hideo Watanabe; Joshua M Francis; Michele S Woo; Banafsheh Etemad; Wenchu Lin; Daniel F Fries; Shouyong Peng; Eric L Snyder; Purushothama Rao Tata; Francesca Izzo; Anna C Schinzel; Jeonghee Cho; Peter S Hammerman; Roel G Verhaak; William C Hahn; Jayaraj Rajagopal; Tyler Jacks; Matthew Meyerson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

9.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.

Authors:  Daichao Xu; Taijie Jin; Hong Zhu; Hongbo Chen; Dimitry Ofengeim; Chengyu Zou; Lauren Mifflin; Lifeng Pan; Palak Amin; Wanjin Li; Bing Shan; Masanori Gomi Naito; Huyan Meng; Ying Li; Heling Pan; Liviu Aron; Xian Adiconis; Joshua Z Levin; Bruce A Yankner; Junying Yuan
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

10.  Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

Authors:  Eric L Snyder; Hideo Watanabe; Margaret Magendantz; Sebastian Hoersch; Tiffany A Chen; Diana G Wang; Denise Crowley; Charles A Whittaker; Matthew Meyerson; Shioko Kimura; Tyler Jacks
Journal:  Mol Cell       Date:  2013-03-21       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.